Key Highlights
•
A large study of adults with intellectual disability and epilepsy in England found that epilepsy was the primary cause of death in 16% of cases, and these individuals died at a significantly younger median age (56 years) than those who died of other causes (62 years). This highlights pervasive health inequalities and missed prevention opportunities in this vulnerable population, pointing to a need for systemic service redesign.
Source →
•
A Japanese claims database study found that patients continuously prescribed the newer dual orexin receptor antagonists for insomnia were 40% more likely to discontinue their medication than those on traditional benzodiazepines. This suggests these newer drugs may have greater clinical utility for insomnia by being less habit-forming, potentially offering a safer long-term treatment option.
Source →
•
A proof-of-concept project successfully linked detailed Alzheimer’s disease research data with real-world electronic health records and Medicare claims for over 2,200 participants. This creates a more complete, powerful dataset that can drive discovery and enable more personalized, precise medicine for Alzheimer’s and related dementias.
Source →
•
A systematic review found that for adults with chronic non-cancer pain, having a documented plan to reduce opioid use was strongly associated with successfully lowering the dose. This identifies a clear, modifiable action clinicians can take to help patients safely reduce their reliance on opioid medications.
Source →
•
A study examining the interplay between physical activity, sedentary behavior, and disease found that these lifestyle factors significantly impact the risk of cardiovascular and respiratory diseases. This reinforces the critical importance of regular movement and reducing sitting time for maintaining long-term heart and lung health.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
